drugset / Trial / NCT02657460

Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion

NCT02657460 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The study is to investigate the anticancer effect and the related immunological mechanism of MTX-ATMPs in the treatment of malignant pleural effusion.

Timeline

Start
2016-01
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified — —
Subject tumor derived microparticles Unknown — —

Indications